Meghana Sathe
Pediatric Gastroenterology · Dallas, TXNPI 1225240096
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (57.9%), speaking fees and food and beverage — rather than concentrated in one kind of arrangement. 29 manufacturers reported payments, led by Alcresta Therapeutics, Inc. at 59.9% of the total. Reporting peaked in 2020 at $10,805 and has fallen 93.4% since, to $718 in 2025. Among pediatric gastroenterology clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 230 payments — averaging $128.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Alcresta Therapeutics, Inc.$18K
- Nestle Healthcare Nutrition Inc.$7K
- AbbVie$2K
- Chiesi USA, Inc.$511
- Vertex$390
- Aimmune Therapeutics, Inc.$350
- plus $2K from 23 others
Across 4 payments — averaging $4757.81 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Vertex$19K
- Vivus LLC$350
What the payments were for
- Consulting fees$17,10058%
- Speaking & faculty fees$7,00024%
- Food & beverage$5,18218%
- Education$1671%
- Gifts$900%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Alcresta Therapeutics, Inc. | 14 | $17,698 |
| Nestle Healthcare Nutrition Inc. | 6 | $6,686 |
| AbbVie(2 entities) | 70 | $1,733 |
| Chiesi USA, Inc. | 38 | $511 |
| Vertex | 14 | $390 |
| Aimmune Therapeutics, Inc. | 10 | $350 |
| Takeda Pharmaceuticals U.S.A., Inc. | 15 | $264 |
| Regeneron Healthcare Solutions, Inc. | 5 | $228 |
| Baxter Healthcare | 4 | $222 |
| QOL Medical, LLC | 7 | $205 |
| Johnson & Johnson | 8 | $199 |
| Mylan Specialty L.p. | 4 | $183 |
| Albireo Pharma, Inc. | 2 | $143 |
| Mirum Pharmaceuticals, Inc. | 6 | $112 |
| Sanofi | 3 | $107 |
| Advanced Respiratory, Inc | 4 | $83 |
| Gilead | 4 | $72 |
| Pharming Healthcare, Inc. | 3 | $60 |
| Vivus LLC | 2 | $39 |
| AstraZeneca | 2 | $39 |
| Digestive Care, Inc. | 1 | $36 |
| Philips North America LLC | 1 | $34 |
| Amgen | 1 | $30 |
| Perspectum Diagnostics Ltd | 1 | $29 |
| Mauna Kea Technologies, Inc. | 1 | $24 |
| Intrabio Inc | 1 | $23 |
| Genentech USA, Inc. | 1 | $15 |
| Ipsen Biopharmaceuticals, Inc | 1 | $14 |
| Travere Therapeutics, Inc. | 1 | $10 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$29,539 in reported general payments places this provider in the 95th percentile of 159 pediatric gastroenterology providers in Texas.
Other pediatric gastroenterology in Dallas
- Naveen MittalDallas$182K
- Amal AqulDallas$99K
- Charina RamirezDallas$60K
- David TroendleDallas$14K
- Nandini ChannabasappaDallas$12K
- Rinarani SanghaviDallas$6K
- Bradley BarthDallas$6K
- Ricardo Medina-CentenoDallas$5K
- Megha MehtaDallas$4K
- Bhaskar GurramDallas$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.